Patents by Inventor Todd Bauer

Todd Bauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Area-efficient physically unclonable function circuit architecture
    Patent number: 9018972
    Abstract: Generating a physically a physically unclonable function (“PUF”) circuit value includes comparing each of first identification components in a first bank to each of second identification components in a second bank. A given first identification component in the first bank is not compared to another first identification component in the first bank and a given second identification component in the second bank is not compared to another second identification component in the second bank. A digital bit value is generated for each comparison made while comparing each of the first identification components to each of the second identification components. A PUF circuit value is generated from the digital bit values from each comparison made.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: April 28, 2015
    Assignee: Sandia Corporation
    Inventors: Thomas Gurrieri, Jason Hamlet, Todd Bauer, Ryan Helinski, Lyndon G. Pierson
  • P-cadherin antibodies
    Patent number: 8974781
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The invention also relates to heavy and light chain immunoglobulins derived from human P-cadherin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human P-cadherin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
    Type: Grant
    Filed: April 4, 2011
    Date of Patent: March 10, 2015
    Assignee: Pfizer Inc.
    Inventors: Christopher Todd Bauer, Maureen Jeri Bourner, Melanie Boyle, Gerald Fries Casperson, David William Griggs, Richard David Head, William Dean Joy, Richard Allen Mazzarella, Ralph Raymond Minter, Mark Allen Moffat, Barrett Richard Thiele, Todd Lee Vanarsdale
  • Increasing Security in Inter-Chip Communication
    Publication number: 20150052364
    Abstract: An apparatus for increasing security in inter-chip communication includes a sending control module, a communication bus, and a receiving control module. The communication bus is coupled between the sending control module and the receiving control module. The sending control module operates to send data on the communication bus, disable the communication bus when threats are detected, or both.
    Type: Application
    Filed: September 23, 2014
    Publication date: February 19, 2015
    Inventors: Nathan J. Edwards, Jason Hamlet, Todd Bauer, Ryan Helinski
  • Increasing security in inter-chip communication
    Patent number: 8874926
    Abstract: An apparatus for increasing security in inter-chip communication includes a sending control module, a communication bus, and a receiving control module. The communication bus is coupled between the sending control module and the receiving control module. The sending control module operates to send data on the communication bus, disable the communication bus when threats are detected, or both.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: October 28, 2014
    Assignee: Sandia Corporation
    Inventors: Nathan J. Edwards, Jason Hamlet, Todd Bauer, Ryan Helinski
  • P-CADHERIN ANTIBODIES
    Publication number: 20110182884
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The invention also relates to heavy and light chain immunoglobulins derived from human P-cadherin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human P-cadherin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
    Type: Application
    Filed: April 4, 2011
    Publication date: July 28, 2011
    Inventors: Christopher Todd Bauer, Maureen Jeri Bourner, Melanie Boyle, Gerald Fries Casperson, David William Griggs, Richard David Head, William Dean Joy, Richard Allen Mazzarella, Ralph Raymond Minter, Mark Allen Moffat, Barrett Richard Thiele, Todd Lee Vanarsdale
  • P-cadherin antibodies
    Patent number: 7928214
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The invention also relates to heavy and light chain immunoglobulins derived from human P-cadherin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human P-cadherin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
    Type: Grant
    Filed: October 10, 2008
    Date of Patent: April 19, 2011
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: Christopher Todd Bauer, Maureen Jeri Bourner, Melanie Boyle, Gerald Fries Casperson, David William Griggs, Richard David Head, William Dean Joy, Richard Allen Mazzarella, Ralph Raymond Minter, Mark Allen Moffat, Barrett Richard Thiele, Todd Lee Vanarsdale
  • P-CADHERIN ANTIBODIES
    Publication number: 20090118487
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The invention also relates to heavy and light chain immunoglobulins derived from human P-cadherin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human P-cadherin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
    Type: Application
    Filed: October 10, 2008
    Publication date: May 7, 2009
    Inventors: CHRISTOPHER TODD BAUER, MAUREEN JERI BOURNER, MELANIE BOYLE, GERALD FRIES CASPERSON, DAVID WILLIAM GRIGGS, RICHARD DAVID HEAD, WILLIAM DEAN JOY, RICHARD ALLEN MAZZARELLA, RALPH RAYMOND MINTER, MARK ALLEN MOFFAT, BARRETT RICHARD THIELE, TODD LEE VANARSDALE
  • P-cadherin antibodies
    Patent number: 7452537
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The invention also relates to heavy and light chain immunoglobulins derived from human P-cadherin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human P-cadherin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: November 18, 2008
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: Christopher Todd Bauer, Maureen Jeri Bourner, Melanie Boyle, Gerald Fries Casperson, David William Griggs, Richard David Head, William Dean Joy, Richard Allen Mazzarella, Ralph Raymond Minter, Mark Allen Moffat, Barrett Richard Thiele, Todd Lee Vanarsdale